Skip to content

Clinical Study on Shenteng Yangxue Granules in Promoting Gastrointestinal Function Recovery of BPF Patients After Pedicled Omentum Transplantation

Clinical Study on Shenteng Yangxue Granules in Promoting Gastrointestinal Function Recovery of BPF Patients After Pedicled Omentum Transplantation

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000137
Enrollment
Unknown
Registered
2026-01-24
Start date
2025-01-25
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

BronchoPleural Fistula

Interventions

control group:The control group received surgical treatment alone.
experimental group :Shenteng Yangxue Granules

Sponsors

The Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
23 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Signed the informed consent form for surgery;(2) Admission time: January 25, 2025 - January 25, 2026;(3) Inpatients in the Department of Thoracic Surgery, who meet the Western medicine and Traditional Chinese Medicine diagnostic criteria for Bronchopleural Fistula (BPF) and Postoperative Gastrointestinal Dysfunction (POGD), with no restriction on gender;(4) Voluntarily receive pedicled omentum transplantation for treatment;(5) Patients who meet the criteria for drug treatment were divided into two groups: the group treated with Canteng Yangxue Granules combined with surgery, and the group treated with surgery alone.

Exclusion criteria

Exclusion criteria: (1) Patients or their family members refuse to sign the informed consent form;(2) Critically ill patients with severe dyspnea that endangers their life safety;(3) Patients with severe organic diseases of important organs such as the heart, brain, liver, and kidneys, severe primary diseases of the hematopoietic system, or abnormal liver and kidney function;(4) Patients with cognitive impairment or communication difficulties;(5) Patients with a history of previous abdominal surgery, or a preoperative history of intestinal obstruction or constipation;(6) Patients with autoimmune diseases (inflammatory bowel disease, including ulcerative colitis, Crohn's disease, or indeterminate colitis);(7) Patients with complicated benign or malignant digestive tract diseases.

Design outcomes

Primary

MeasureTime frame
Time to First Postoperative Flatus ;Time to first postoperative defecation;

Secondary

MeasureTime frame
Gastrointestinal Symptom Rating Scale;White Blood Cell Count;C-reactive protein;Procalcitonin;Postoperative Length of Stay;Quality of Life( Short Form-12 Health Survey);

Countries

China

Contacts

Public Contactyeliang

The Seventh People's Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

yeliangemail@163.com17317507973

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 7, 2026